METABOLISM OF AMINOGLUTETHIMIDE IN HUMANS - IDENTIFICATION OF HYDROXYLAMINOGLUTETHIMIDE AS AN INDUCED METABOLITE

被引：32

作者：

JARMAN, M ^{[1
]}

FOSTER, AB ^{[1
]}

GOSS, PE ^{[1
]}

GRIGGS, LJ ^{[1
]}

HOWE, I ^{[1
]}

COOMBES, RC ^{[1
]}

机构：

[1] LUDWIG INST CANC RES,SUTTON SM2 5PX,SURREY,ENGLAND

来源：

BIOMEDICAL MASS SPECTROMETRY | 1983年 / 10卷 / 11期

关键词：

D O I：

10.1002/bms.1200101108

中图分类号：

R318 [生物医学工程];

学科分类号：

0831 ;

摘要：

引用

页码：620 / 625

页数：6

共 21 条

[11]

DOUGLAS JS, 1972, J PHARM PHARM S, V24, P150

[12]

EGGER H, 1982, DRUG METAB DISPOS, V10, P405

[13] ANALOGS OF AMINOGLUTETHIMIDE - SELECTIVE-INHIBITION OF CHOLESTEROL SIDE-CHAIN CLEAVAGE [J].

FOSTER, AB ;

JARMAN, M ;

LEUNG, CS ;

ROWLANDS, MG ;

TAYLOR, GN .

JOURNAL OF MEDICINAL CHEMISTRY, 1983, 26 (01) :50-54

[14] FORMATION AND CRYSTAL-STRUCTURE OF 5-[HYDROXY(PHENYL)AMINO]-3,3,5-TRIMETHYL-2-PHENYLISOXAZOLIDINE AND N-(3,3,5-TRIMETHYL-2-PHENYLISOXAZOLIDIN-5-YL)PHENYLAMINYL N-OXIDE (BANFIELD AND KENYONS RADICAL) [J].

FOSTER, R ;

IBALL, J ;

NASH, R .

JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2, 1974, (10) :1210-1214

[15]

HARLEYMASON J, 1958, BIOCHEM J, V69, P60

[16]

HOPKINS BJ, 1974, INTRO SPECTROSCOPIC, V2, P317

[17] SERUM AMINOGLUTETHIMIDE LEVELS - STUDIES OF SERUM HALF-LIFE, CLEARANCE, AND PATIENT COMPLIANCE [J].

MURRAY, FT ;

SANTNER, S ;

SAMOJLIK, E ;

SANTEN, RJ .

JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 19 (11-1) :704-711

[18] FRAGMENTATION PROCESS OF GLUTETHIMIDE IN MASS SPECTROMETER [J].

RUCKER, G ;

BOHN, G .

ARCHIV DER PHARMAZIE UND BERICHTE DER DEUTSCHEN PHARMAZEUTISCHEN GESSELSCHAFT, 1969, 302 (03) :204-&

[19]

WATERS WA, 1976, J CHEM SOC PERK T 2, P732, DOI 10.1039/p29760000732

[20] MEDICAL ADRENALECTOMY WITH AMINOGLUTETHIMIDE - CLINICAL STUDIES IN POST-MENOPAUSAL PATIENTS WITH METASTATIC BREAST CARCINOMA [J].

WELLS, SA ;

SANTEN, RJ ;

LIPTON, A ;

HAAGENSEN, DE ;

RUBY, EJ ;

HARVEY, H ;

DILLEY, WG .

ANNALS OF SURGERY, 1978, 187 (05) :475-484

← 1 2 3 →